At the risk of starting a flamewar... wasn't the difference actually just the pure volume of severe sickness and death? The clinical trials didn't even attempt to test viral spread, they tested prevention of symptoms.

If suddenly 50% of the world population got breast cancer at once, I'm willing to bet we'd be fine rolling out new technologies faster than the typical standard, despite it being non-contagious.